Becton, Dickinson & Co. Stock
Becton, Dickinson & Co. Stock
A loss of -2.750% shows a downward development for Becton, Dickinson & Co..
Becton, Dickinson & Co. is currently one of the favorites of our community with 11 Buy predictions and no Sell predictions.
As a result the target price of 175 € shows a positive potential of 21.91% compared to the current price of 143.55 € for Becton, Dickinson & Co..
Pros and Cons of Becton, Dickinson & Co. in the next few years
Pros
?
M***** P*******
?
C******** o* t** e**********
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Becton, Dickinson & Co. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Becton, Dickinson & Co. | -2.750% | 9.609% | 8.318% | -6.838% | -11.489% | -42.181% | -31.494% |
| Dexcom Inc. | -2.430% | 4.777% | 7.166% | -14.965% | 14.794% | -45.203% | -31.458% |
| Baxter International | 7.770% | 13.514% | 12.247% | -13.463% | 32.765% | -49.285% | -66.774% |
| Idexx Laboratories Inc. | -2.970% | 4.250% | 6.162% | 0.322% | -14.831% | -0.738% | -16.037% |
Comments
Becton, Dickinson and Company (BDX) was given a new $190.00 price target by UBS Group AG. They now have a "buy" rating on the stock.
Show more
Ratings data for BDX provided by MarketBeat
Becton, Dickinson and Company (BDX) is now covered by UBS Group AG. They set a "buy" rating on the stock.
Show more
Ratings data for BDX provided by MarketBeat
Becton, Dickinson and Company (BDX) had its price target lowered by Argus from $230.00 to $180.00. They now have a "buy" rating on the stock.
Show more
Ratings data for BDX provided by MarketBeat
News
Becton, Dickinson and Company Q2 Earnings Call Highlights
Becton, Dickinson and Company (NYSE:BDX) reported fiscal second-quarter revenue and adjusted earnings ahead of its internal
The Healthcare Stock Built for Investors Who Prioritize Capital Preservation
Wanting to invest in healthcare is a savvy instinct. It is, after all, a major expense in America. Per the Peterson-KFF Health System Tracker, "On a per capita basis, total health spending
